share_log

Hubei Yihua Chemical Industry's (SZSE:000422) Anemic Earnings Might Be Worse Than You Think

Hubei Yihua Chemical Industry's (SZSE:000422) Anemic Earnings Might Be Worse Than You Think

湖北宜化化工(深圳證券交易所代碼:000422)的疲軟收益可能比你想象的還要糟糕
Simply Wall St ·  04/25 19:13

The market wasn't impressed with the soft earnings from Hubei Yihua Chemical Industry Co., Ltd. (SZSE:000422) recently. Our analysis has found some reasons to be concerned, beyond the weak headline numbers.

湖北宜化化工股份有限公司(SZSE: 000422)最近的疲軟收益並沒有給市場留下深刻的印象。我們的分析發現,除了疲軟的標題數字外,還有一些令人擔憂的理由。

earnings-and-revenue-history
SZSE:000422 Earnings and Revenue History April 25th 2024
SZSE: 000422 2024 年 4 月 25 日的收益和收入歷史記錄

In order to understand the potential for per share returns, it is essential to consider how much a company is diluting shareholders. In fact, Hubei Yihua Chemical Industry increased the number of shares on issue by 18% over the last twelve months by issuing new shares. As a result, its net income is now split between a greater number of shares. Per share metrics like EPS help us understand how much actual shareholders are benefitting from the company's profits, while the net income level gives us a better view of the company's absolute size. You can see a chart of Hubei Yihua Chemical Industry's EPS by clicking here.

爲了了解每股回報的可能性,必須考慮公司在多大程度上稀釋了股東。實際上,湖北宜化化工通過發行新股,在過去十二個月中將已發行股票數量增加了18%。結果,其淨收入現在分成了更多的股票。每股收益等每股指標可以幫助我們了解實際股東從公司的利潤中受益的程度,而淨收入水平則使我們能夠更好地了解公司的絕對規模。您可以點擊此處查看湖北宜化化工每股收益圖表。

A Look At The Impact Of Hubei Yihua Chemical Industry's Dilution On Its Earnings Per Share (EPS)

看看湖北宜化化工的稀釋對其每股收益(EPS)的影響

As you can see above, Hubei Yihua Chemical Industry has been growing its net income over the last few years, with an annualized gain of 115% over three years. But EPS was only up 100% per year, in the exact same period. Net income was down 79% over the last twelve months. Unfortunately for shareholders, though, the earnings per share result was even worse, declining 81%. So you can see that the dilution has had a bit of an impact on shareholders.

如上所示,湖北宜化化工在過去幾年中淨收入一直在增長,三年內年化增長115%。但是在同一時期,每股收益每年僅增長100%。在過去的十二個月中,淨收入下降了79%。但不幸的是,對於股東來說, 每股收益 結果甚至更糟,下降了81%。因此,你可以看到稀釋對股東產生了一些影響。

In the long term, if Hubei Yihua Chemical Industry's earnings per share can increase, then the share price should too. But on the other hand, we'd be far less excited to learn profit (but not EPS) was improving. For the ordinary retail shareholder, EPS is a great measure to check your hypothetical "share" of the company's profit.

長期來看,如果湖北宜化化工的收益 每股 可以上漲,那麼股價也應該上漲。但另一方面,得知利潤(但不是每股收益)在改善,我們就不那麼興奮了。對於普通零售股東來說,每股收益是檢查您假設的公司利潤 “份額” 的好方法。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Hubei Yihua Chemical Industry's Profit Performance

我們對湖北宜化化工盈利表現的看法

Over the last year Hubei Yihua Chemical Industry issued new shares and so, there's a noteworthy divergence between EPS and net income growth. Because of this, we think that it may be that Hubei Yihua Chemical Industry's statutory profits are better than its underlying earnings power. But the good news is that its EPS growth over the last three years has been very impressive. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. For example - Hubei Yihua Chemical Industry has 4 warning signs we think you should be aware of.

在過去的一年中,湖北宜化化工發行了新股,因此,每股收益和淨收入增長之間存在明顯的差異。因此,我們認爲可能是湖北宜化化工的法定利潤要好於其基礎盈利能力。但好消息是,其在過去三年中的每股收益增長非常令人印象深刻。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。請記住,在分析股票時,值得注意所涉及的風險。例如,湖北宜化化工有 4 個警示標誌,我們認爲您應該注意。

This note has only looked at a single factor that sheds light on the nature of Hubei Yihua Chemical Industry's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

這份報告只研究了揭示湖北宜化化工利潤性質的單一因素。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。有些人認爲高股本回報率是優質業務的好兆頭。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論